Manank Turakhia

Manank Turakhia

Active Director Director DIN 09495364
DIN 09495364 First appointment Feb 2022 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2022
Shareholding value •••• Premium profile

About Manank Turakhia

Data last updated:

Manank Turakhia is a Director at Adventus Meditech (India) Private Limited (since 2022). The company operates in Healthcare. Adventus Meditech (India) Private Limited reported revenue of ₹2.38 Cr (FY 2025).

DIN 09495364
Primary Designation Director
Industry Healthcare
First Appointment 07 Feb 2022
Oldest Company Age 4 yrs
Largest company Adventus Meditech (India) Private Limited · ₹2.38 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director07 Feb 20222022₹2.38 Cr (FY 2025)Active

Board colleagues of Manank Turakhia

Directorship timeline

Open interactive timeline →
Adventus Meditech (India) Private Limited
Premium access

Shareholding and investment profile for Manank Turakhia

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manank Turakhia

Manank Turakhia currently holds 1 directorship: Adventus Meditech (India) Private Limited (Director, since 07 Feb 2022, revenue ₹2.38 Cr (FY 2025)).

Manank Turakhia was first appointed on 07 Feb 2022 as Director at Adventus Meditech (India) Private Limited.

The current boards of Manank Turakhia's companies include Nirav Subodhkumar Turakhia (Adventus Meditech (India) Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available